Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Apetiviton BC
- Development stage
- Unknown
- Lead developer
- Cifarma
- Modality
- Small Molecules
- Administration
- Oral
01
Overview
Apetiviton BC is an appetite stimulant and vitamin supplement developed by Cifarma Cientifica Farmaceutica. It is a combination product containing cyproheptadine hydrochloride, a first-generation antihistamine with potent antiserotonergic properties, along with a complex of B vitamins (B1, B2, B3, B6) and Vitamin C. The primary mechanism for appetite stimulation is attributed to cyproheptadine's antagonism of serotonin 5-HT2 receptors in the hypothalamus, which are involved in satiety signaling. By blocking these receptors, the drug helps to increase appetite and promote weight gain in patients suffering from inappetence. The included vitamins serve as essential cofactors in energy metabolism and help address potential nutritional deficiencies associated with poor dietary intake. It is typically administered as an oral solution and is used in pediatric, adult, and elderly populations.
- Brand names
- Apetiviton BC
02
Targets
HTR2C (5-hydroxytryptamine 2C receptor)mAChR (Muscarinic acetylcholine receptors)HTR2A (Serotonin receptor 5-HT2A)HRH1 (Histamine H1 Receptor)
Beyond the preview
Go deeper on Apetiviton BC.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Apetiviton BC.